Dr. Reddy’s Omeprazole Case: Is Pediatric Exclusivity Extension Of Patent?

Dr. Reddy's legal rationale for why it should get 180-day exclusivity for 40 mg omeprazole could include an argument that pediatric exclusivity be treated as an extension of the drug's patent life

More from Archive

More from Pink Sheet